UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: December 1, 2022 4:00 P.M.
Form: F-1
CIK: 0001885827
Company Name: Virax Biolabs Group Ltd
File Number: 333-268486